On-demand PPI Therapy is Effective on Controlling Symptoms in Patients With Barrett's Esophagus.

NCT04329000 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 218

Last updated 2020-04-03

No results posted yet for this study

Summary

On-demand PPI therapy is feasible for the long-term treatment of patients with Barrett's esophagus.

Conditions

  • Barrett Esophagus
  • Proton Pump Inhibitor
  • Symptom
  • Reflux

Interventions

DRUG

Esomeprazole 40mg

On-demand Esomeprazole 40 mg QD

DRUG

Esomeprazole

Continuous Esomeprazole 40 mg QD

Sponsors & Collaborators

  • Kaohsiung Veterans General Hospital.

    lead OTHER

Principal Investigators

  • SUNG-SHUO KAO, Bachelor · Kaohsiung Veterans General Hospital.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-02
Primary Completion
2019-02-13
Completion
2019-12-08

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04329000 on ClinicalTrials.gov